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A B S T R A C T
Background: Insulin resistance (IR) is characterized as a metabolic disorder syndrome that is upstream of
hypertension, dyslipidemia, and diabetes mellitus (DM). This study investigated exercise training effects
on the exercise tolerance and heart rate dynamics in patients with IR or pancreatic b-cell dysfunction.
Methods: Seventy patients (mean age, 60.1 years) with myocardial infarction (MI) participating in a
phase II cardiac rehabilitation program were studied. Patients diagnosed with DM were excluded.
Homeostasis model-assessment indices were used to divide patients into three groups – A: IR; B:
normal; and C: b-cell dysfunction.
A cardiopulmonary exercise test (CPX) was performed and peak oxygen uptake (V˙O2) was measured.
After baseline testing, subjects participated in a supervised, combined aerobic and resistance exercise
program.
Results: Peak V˙O2 at baseline was comparable among the three groups, and it improved after training in
all groups (p < 0.05). However, both the increase and percentage increase in peak V˙O2 were smaller in
Group C than in Group A (p < 0.05). Heart rate (HR) reserve (peak HRrest HR), and HR recovery
immediately 1 min after exercise during CPX were calculated in 45 patients who were not taking
negative chronotropic agents. Group C alone did not show any signiﬁcant increase in HR reserve. HR
reserve at both baseline and after training had signiﬁcant positive correlations with peak V˙O2. HR
recovery was 1.9 beats/min lower in group C than group A, but this was not signiﬁcant. HR recovery in
group C did not increase after cardiac rehabilitation.
Conclusion: Impaired HR reserve increase after training in patients with pancreatic b-cell dysfunction
attenuates exercise training effects on functional capacity. Comprehensive treatment including vigorous
exercise training will be needed in such prediabetic patients.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Recently, the number of patients diagnosed with diabetes
mellitus (DM) has increased dramatically in both Western and
Asian countries [1]. Over 20 million individuals have deﬁnitive or* Corresponding author at: St. Marianna University Yokohama City Seibu Hospital,
Cardiology, 1197-1 Yasashi-cho, Asahi-ku, Yokohama, Kanagawa 241-0811, Japan.
Tel.: +81 453661111; fax: +81 453661190.
E-mail address: omiya@marianna-u.ac.jp (K. Omiya).
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0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsborderline DM in Japan, and approximately 40% of patients with
acute myocardial infarction (MI) treated at our hospital have DM [2].
Similar to other studies [3,4], we had previously reported that
maximum oxygen uptake (peak V˙O2) was attenuated in patients
with acute MI complicated with DM compared with patients with MI
and without DM [2,5,6]. We also reported that exercise tolerance in
DM patients remained low after 3 months of exercise training
compared with non-DM patients, and we speculated that blunted
heart rate (HR) response to sympathetic nerve stimulation may be
the cause of reduced peak V˙O2 and blunted training effects [2,5,6]. reserved.
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of metabolic disorder that exists upstream of hypertension,
dyslipidemia, and DM, but also as an alternative risk factor for
atherosclerosis and poor prognosis [7]. However, little is known
about how exercise training effects are inﬂuenced by IR and
pancreatic b-cell dysfunction. In this study, we investigated
differences in exercise training effects in patients with IR or
pancreatic b-cell dysfunction. We also investigated whether
exercise training effects are inﬂuenced by HR response in prediabetic
patients and DM patients
Methods
Subjects
This study included 70 patients (58 men, 12 women, mean age
60.1  10.8 years) with acute MI who were participating in phase I
and phase II cardiac rehabilitation program at our hospital. All the
patients successfully underwent revascularization therapy of dis-
eased vessels in the acute phase, and no severe complications were
present during hospitalization or after discharge. This study was
approved by the Ethics Committee of our University (Certiﬁcation No.
356), and all the participating patients provided written informed
consent. The exclusion criteria were inability to perform exercise test,
chronic obstructive pulmonary disease, orthopedic disorders, uncon-
trollable ventricular arrhythmia, uncontrolled heart failure, chronic
atrial ﬁbrillation, and a previous history of MI. Patients diagnosed
with DM before, and patients who were taking any antidiabetic
agents including thiazolidines or biguanides to improve insulin
sensitivity were not included in this study. The diagnostic criteria of
DM were a fasting blood sugar (FBS) equal to or greater than 126 mg,
or a post-prandial glucose equal to or greater than 200 mg/dL, or a
120 min glucose level after the 75 g oral glucose tolerance test (OGTT)
was equal to or greater than 200 mg/dL, combined with a hemoglobin
A1c greater than 6.5% (National Glycohemoglobin Standardization
Program). All the patients underwent a 75 g OGTT to screen for DM
during hospitalization.
Methods
Serum FBS and immunoreactive insulin (IRI) were measured at
rest in the early morning during hospitalization. The blood tests
were performed after the patients were in stable condition, and IR
and pancreatic b-cell function were evaluated using homeostasis
model assessment (HOMA) [8]. HOMA indices were calculated as
follows:
HOMA-IR ¼ IRI ðmU=mLÞ  FBS ðmg=dLÞ=405
HOMA-b ¼ IRI  360=ðFBS-63Þ
Serum high-density lipoprotein (HDL) cholesterol and low-
density lipoprotein (LDL) cholesterol were also measured at
baseline and at 3 months after the rehabilitation period.
Cardiopulmonary exercise testing
Before exercise training, we performed cardiopulmonary
exercise testing (CPX) approximately 1 month after the onset of
MI. CPX was performed on a MAT-2500 treadmill (Fukuda Denshi
Co., Tokyo, Japan) using an exercise protocol that we developed for
the treadmill test [9], in which exercise load intensity increases
gradually by approximately one metabolic equivalent every
minute by increasing speed or slope. HR response, ST-T changes,
and arrhythmias during the exercise test were monitored
continuously with an ML-5000 stress-test system (Fukuda Denshi
Co.). A standard 12-lead electrocardiogram was recorded andexamined every minute. Blood pressure (BP) was also recorded
with an STBP-780 automated sphygmomanometer (Colin Co.,
Aichi, Japan) every minute. The criteria for halting exercise testing
in this study are outlined in the guidelines of the American College
of Sports Medicine [10]. The exercise test was performed without a
cool-down exercise phase and patients sat down in a chair
immediately after ﬁnishing the exercise test, while in the recovery
phase.
Expired gas analysis was performed throughout testing using a
breath-by-breath method with an AE-300S cart (Minato Medical
Science, Osaka, Japan). The parameters determined from the CPX
were the anaerobic threshold (AT), peak V˙O2, and slope of the
ventilatory equivalent (V˙E) to carbon dioxide output (V˙CO2; i.e. the
V˙E vs. V˙CO2 slope). Gas exchange ratio (GER) during exercise was
obtained by V˙CO2=V˙O2. These parameters were calculated with the
accessory software of the AE-300S.
Knee extension muscular strength measurement
A Biodex System 2 isokinetic dynamometer (Biodex Medical
Systems, Inc., Shirley, NY, USA) was used for the knee extension
muscular strength measurement. The machine was calibrated at
the beginning of the study. The measurements were performed
according to the method we previously described [11]. Isokinetic
test results were analyzed with Biodex System 2 software. We
measured the knee extension muscular strength peak torque (PT)
per body weight value of both the right and left knees, and used the
maximum obtained value as the index of knee extension muscular
strength.
Exercise training
Exercise training was performed based on the results of CPX and
the muscle strength test. After baseline testing, outpatients
participated in a supervised combined aerobic and resistance
exercise program twice a week for 1 h. Aerobic exercise intensity
was maintained at HR at approximately the AT level during
treadmill walking. For resistance training, four sets of a series of
two upper-extremity exercises (shoulder ﬂexion and abduction
from anatomic position) were performed with an iron weight array
at a resistance that allowed completion of ﬁve repetitions with a
rating of perceived exertion (RPE) of 1113 (according to the Borg
620 scale) [12]. Four sets of a series of knee extensions and calf
raises were performed as lower-extremity exercises. Exercise
intensity for calf raises was also maintained at a RPE of 1113.
Each session was preceded and followed by a series of upper- and
lower-extremity and body stretches.
Evaluation of HOMA indices
We deﬁned IR as a HOMA-IR > 2.0, and impaired b-cell function
as a HOMA-b < 50 (%). Both deﬁnitions were obtained by using
data from previous reports [13,14].
Patients in this study were divided into three groups: A, insulin
resistance group with HOMA-IR > 2.0 and HOMA-b > 50%; B,
normal group with HOMA-IR < 2.0 and HOMA-b > 50%; and C,
impaired b-cell function group with HOMA-IR < 2.0 and HOMA-
b < 50%. Comparisons were made between these three groups.
Statistics
All data are expressed as mean  standard deviation. A paired
Student’s t-test was used to evaluate the differences before and after
exercise training. Chi-square tests were used to analyze patients’
background and analysis of variance (ANOVA) followed by multiple
comparisons with Tukey’s test was used to analyze the differences
Table 2
Changes of clinical values pre- and post-rehabilitation.
A: Insulin
resistance
B: Normal C: b-cell
dysfunction
p-Value
BMI
Pre 24.3  2.3 23.3  2.9 22.6  2.5 <0.05
Post 24.0  2.3* 23.1  2.4 22.6  2.5 ns
IRI
Pre 11.2  2.7 6.0  1.5 4.2  1.2 <0.01
Post 9.1  4.8 5.2  2.6 4.5  1.3 <0.01
FBS (mg/dl)
Pre 104.8  12.8 93.7  6.6 107.1  13.3 <0.01
Post 101.5  7.9 99.7  6.9 109.2  12.7 <0.05
HOMA-IR
Pre 2.94  0.98 1.40  0.39 1.13  0.39 <0.01
Post 2.30  1.20* 1.29  0.68 1.23  0.43 <0.01
HOMA-b
Pre 105.1  41.3 71.7  17.6 35.7  10.5 <0.01
Post 74.0  35.8 54.4  27.2* 36.9  11.9 <0.01
LDL-C (mg/dL)
Pre 99.8  27.3 107.5  22.5 116.7  22.2 ns
Post 95.8  23.7 98.9  31.4* 107.6  26.6* ns
HDL-C (mg/dL)
Pre 39.7  12.8 40.7  8.8 37.3  8.8 ns
Post 50.8  11.8* 48.6  9.1** 52.7  12.6** ns
Peak V˙O2
(mL/min/kg)
Pre 24.5  4.3 26.1  5.2 25.7  5.4 ns
Post 29.4  5.0** 29.4  6.4** 28.2  6.5** ns
DPeak V˙O2
(mL/min/kg)
4.89  4.06 3.32  3.03 2.47  2.14 <0.05
%DPeak V˙O2 (%) 21.6  21.3 13.2  11.9 9.4  7.7 <0.05
V˙E vs. V˙CO2 slope
Pre 28.7  3.8 28.8  3.6 28.6  3.9 ns
Post 27.6  3.8* 27.7  3.1** 27.3  3.7** ns
PT (Nm/kg)
Pre 1.79  0.41 1.88  0.52 1.87  0.52 ns
Post 1.90  0.48** 2.05  0.53** 2.07  0.56** ns
BMI, body mass index; IRI, immunoreactive insulin; FBS, fasting blood sugar;
HOMA, homeostasis model assessment; IR, insulin resistance; LDL-C, low-
density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol;
V˙O2, oxygen uptake; D, increase; V˙E, minute ventilation; V˙CO2, carbon dioxide
output; PT, peak torque.
* p < 0.05 vs. pre.
** p < 0.01 vs. pre.
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assessed by using Pearson’s correlation coefﬁcient. A p-value of <0.05
was considered signiﬁcant. Data were evaluated by using the
commercially available statistical software SPSS version 18 (IBM
Co., Tokyo, Japan).
Results
Group A comprised 23 patients; Groups B and C comprised 23
and 24 patients, respectively. Patient characteristics in each group
are listed in Table 1. None of the subjects terminated exercise
testing for severe cardiac ischemia or ventricular arrhythmia. All
the patients underwent exercise testing until near exhaustion with
a peak GER greater than 1.10.
Baseline and changes in HOMA indices and lipid proﬁle
Although body mass index in Group A at baseline was
signiﬁcantly higher than that in Group C (p < 0.05), no signiﬁcant
difference was seen after training (Table 2). At baseline, both IRI
and FBS in Group A were higher than those in Group B (p < 0.01,
respectively). In Group C, IRI at baseline was lower than that in
Group A and Group B (p < 0.01, p < 0.05, respectively), and FBS was
higher than Group B (p < 0.01).
A positive correlation between HOMA-IR and HOMA-b was
obtained at entry (r = 0.55, p < 0.001). Both HOMA-IR and HOMA-b
at baseline in Group A were signiﬁcantly greater than those in
Groups B and C (p < 0.01). After training, HOMA-IR improved in
Group A only, in which patients had IR and maintained b-cell
function (from 2.94 to 2.30, p < 0.05). HOMA-b changed only in
Group B (71.7% to 54.4%, p < 0.05). HDL cholesterol increased
signiﬁcantly in all three groups, and LDL cholesterol decreased
signiﬁcantly in Groups B and C after the 3-month rehabilitation
period (p < 0.05).
Changes in peak V˙O2 and the V˙E vs. V˙CO2 slope
The peak V˙O2 at baseline was comparable among Groups A, B,
and C (24.5, 26.1, and 25.7 mL/min/kg, respectively). After training,
they improved to 29.4, 29.4, and 28.2 mL/min/kg, respectively
(p < 0.01). However, both the increase and percentage increase inTable 1
Characteristics of study population in each group.
A: Insulin
resistance
(n = 23)
B: Normal
(n = 23)
C: b-cell
dysfunction
(n = 24)
p-Value
Age (years) 61.8  6.9 57.3  12.5 61.2  9.8 ns
Male 18 (78.3) 19 (82.6) 21 (87.5) ns
LVEF (%) 55.3  10.3 52.1  9.8 49.9  13.4 ns
HbA1c (%) 5.52  0.41 5.48  0.35 5.61  0.38 ns
MI site
Anterior 13 (56.5) 11 (47.8) 12 (50.0) ns
Inferior 6 (26.1) 8 (34.8) 11 (45.8) ns
Other 4 (17.4) 4 (17.4) 1 (4.2) ns
Drugs
ACEI 14 (60.9) 12 (52.2) 12 (50.0) ns
ARB 7 (30.4) 10 (43.5) 10 (41.7) ns
b-blocker 7 (30.4) 10 (43.5) 8 (33.3) ns
Statin 12 (52.2) 15 (65.2) 15 (62.5) ns
Fibrate 2 (8.7) 0 1 (4.2) ns
Aspirin 23 (100) 23 (100) 22 (91.7) ns
Warfarin 4 (17.4) 4 (17.4) 2 (8.3) ns
Diuretics 3 (13.0) 2 (8.7) 1 (4.2) ns
Values are mean  SD or n (%). ns, not signiﬁcant; LVEF, left ventricular ejection
fraction; HbA1c, glycated hemoglobin A1c; MI, myocardial infarction; ACEI,
angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.peak V˙O2 were lower in Group C than Group A, (p < 0.05). V˙E vs.
V˙CO2 slope was comparable among the three groups (28.7, 28.8,
and 28.6, respectively) and signiﬁcantly decreased in all three
groups, but no inter-group difference was obtained after training
(Table 2, Fig. 1).Fig. 1. Comparison of percentage increase in peak V˙O2 among the three groups.
Percentage increase in peak V˙O2 in the Group A was signiﬁcantly higher than that of
the Group C. ANOVA, analysis of variance; V˙O2, oxygen uptake.
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The maximum knee extensor power was comparable between
the three groups both at baseline and after 3 months of training
(Table 2). PT increased signiﬁcantly in all groups and the
percentage increase in PT had no signiﬁcant inter-group difference.
Heart rate reserve and heart rate recovery in patients who do not use
b-blockers or other negative chronotropic agents
In these subjects, HR dynamics were evaluated by using HR
during CPX. This sub-analysis was performed in patients not
taking b-blockers, digitalis, verapamil, or other negative chron-
otropic agents that inﬂuence HR dynamics. The number of
subjects who were not taking such drugs was 45 (16, 14, and
15 patients in Groups A, B, and C, respectively). HR reserve was
calculated as peak HRrest HR, and was obtained during CPX.
Chronotropic response (CR, %) was calculated as 100  peak HR/
220  age (estimated peak HR). Additionally, HR recovery
immediately after the exercise test was obtained as peak HR–
HR 1 min after exercise.
In this sub-study group, the same results of reduced peak V˙O2
increase in Group C and comparable knee muscle strength were
obtained.
HR reserve both at baseline and after training was comparable
among the three groups. Although the HR recovery in Groups A and
B signiﬁcantly increased after training (baseline vs. after training:
73.4 vs. 85.5, 74.6 vs. 83.5, respectively, p < 0.01), it was
unchanged in Group C (76.7 vs. 80.4) (Table 3).
HR reserve both at baseline and after training was signiﬁcantly
correlated with peak oxygen uptake (r = 0.57 and 0.55, respective-
ly, p < 0.01), and the increase in HR reserve from baseline to after
training was positively correlated with the increase in peak V˙O2
(r = 0.32, p < 0.05).
Correlation between percentage increase in CR and increase
in muscle strength
A rough, but signiﬁcant positive correlation was obtained
between percentage increase in CR and the increase in muscle
strength (r = 0.24, p < 0.05).Table 3
Changes in HR dynamics pre- and post-rehabilitation (n = 45).
A: Insulin
resistance
B: Normal C: b-cell
dysfunction
p-Value
Rest HR (beats/min)
Pre 77.7  12.5 71.0  10.7 76.1  7.9 ns
Post 70.1  11.6*** 69.9  8.1 75.6  10.4 ns
Peak HR (beats/min)
Pre 151.1  19.5 145.6  16.6 152.8  22.3 ns
Post 155.6  13.1 153.4  16.5* 156.0  17.7 ns
HR reserve (beats/min)
Pre 73.4  17.1 74.6  12.2 76.7  20.8 ns
Post 85.5  12.9*** 83.5  13.5** 80.4  19.6 ns
CR (%)
Pre 92.6  22.8 82.9  11.5 96.7  23.5 ns
Post 97.8  14.7 91.8  12.7* 100.2  18.4 ns
DCR (%) 5.2  13.9 8.9  11.8 3.6  14.5 ns
%DCR (%) 9.2  17.9 11.8  16.1 6.2  16.4 ns
HR recovery (beats/min)
Pre 26.5  8.4 25.9  10.8 24.6  8.9 ns
Post 32.5  9.9* 26.9  8.8 28.9  9.8 ns
HR, heart rate; CR, chronotropic response; DCR, increase in chronotropic
response.
* p < 0.05 vs. pre.
** p < 0.01 vs. pre.
*** p < 0.0001 vs. pre.HR recovery among three groups and prevalence of impaired HR
recovery
HR recovery was 26.5, 25.9, and 24.6 beats/min in Groups A, B,
and C, respectively and was not signiﬁcantly different among the
three groups, although it was 1.9 beats/min lower in Group C than
in Group A. The prevalence of impaired HR recovery after 1 min,
which was deﬁned as 18 beats/min [15], is more frequent but not
signiﬁcant in Group C (4 out of 15) compared with Group A and B
(4 out of 16 and 2 out of 14, respectively).
HR recovery at 1 month correlated with peak V˙O2 in overall
(r = 0.51, p < 0.01) and in each group. After training, HR recovery
improved only in Group A (p < 0.05). HR recovery in group C did
not increase after cardiac rehabilitation.
Correlation between HR reserve and HR recovery
Signiﬁcant positive correlations were obtained between HR
reserve and HR recovery post-rehabilitation (r = 0.37, p < 0.05).
Correlations between change in HOMA-b and changes in peak V˙O2,
HR recovery, and HR reserve
No signiﬁcant correlation was obtained between change in
HOMA-b and change in peak V˙O2, HR recovery, and HR reserve,
and also no signiﬁcant correlation was obtained when we analyzed
using percent increase in each parameter.
Discussion
In general, IR occurs upstream of metabolic disorder. It is
thought that the more severe IR, the more frequent progression to
b-cell dysfunction and ﬁnally to DM. However, it was reported that
populations of Asian descent, including that in Japan, had smaller
b-cell number and volume compared with Westerners. This means
that b-cell dysfunction in Japanese will manifest at an early stage
of glucose intolerance and will easily progress to DM. Therefore, it
is important to investigate the IR and b-cell function in patients
with metabolic disorder or atherosclerosis if they have not yet
been diagnosed with DM.
The HOMA-model used in this study is established as an index
of both IR and pancreatic b-cell function [8]. The biggest advantage
of this model over other methods is its simplicity; HOMA indices
can be easily calculated both during hospitalization and at
outpatient clinics by measuring only FBS and IRI. Many investi-
gators have used this model for its convenience although the gold
standard for evaluating IR is a steady-state plasma glucose or the
glucose clamp method. Matthews et al. [8] reported that both IR
and pancreatic b-cell function evaluated by using the HOMA
model were well-correlated with those evaluated by using the
glucose clamp method. IR evaluated by using the HOMA model was
reported to be possibly inaccurate when the subjects’ FBS was
greater than 140150 mg/dL [16]. In the present study, baseline
FBS was uniformly below 126 mg/dL, which is one of the deﬁning
components of DM. In the present study, HOMA-b in the normal
group signiﬁcantly decreased and tended to decrease in the IR
group after training. Insulin secretion may have decreased because
of improved sensitivity after 3 months of training, whereas
pancreatic b-cell function had not yet improved. HOMA-b
decreased on calculation. A longer training period or stronger
training intensity may be necessary for improving HOMA-b.
The most interesting and important result of the present study
is the autonomic dysfunction that was already present in the
prediabetic IR phase, along with pancreatic b-cell dysfunction.
Impaired HR reserve in Group C might be inﬂuenced by autonomic
dysfunction, because the HR recovery, an index of autonomic
K. Omiya et al. / Journal of Cardiology 65 (2015) 128–133132function, was also impaired in Group C, and HR recovery in group C
did not increase after cardiac rehabilitation.
The HR reserve increase was attenuated after rehabilitation;
the impairment in HR reserve increase directly inﬂuenced
the improvement in exercise capacity. Impaired HR reserve
increase after training was speculated to reﬂect low cardiac
output increase after exercise training and may be caused by
autonomic dysfunction or diastolic dysfunction as in patients with
DM. In this study, exercise tolerance was positively correlated with
HR reserve and its increase was limited in patients with attenuated
pancreatic b-cell function. As in our previous studies on MI
complicated with DM [2,5,6], HR reserve may already be
attenuated during b-cell dysfunction (the prediabetic phase).
The precise mechanism of reduced HR reserve in these patients
remains unclear. However, we speculated that cardiac autonomic
nervous dysfunction, as in the systemic nervous system, may
already have begun in this prediabetic phase.
Yufu et al. [17] reported that autonomic dysfunction occurs in the
advanced stage of diabetes, and can be a prognostic predictor for
patients with DM. On the other hand, baroreﬂex sensitivity (BRS), an
index of cardiac autonomic function, is reportedly impaired in the
prediabetic hyperglycemic state as well as DM [18]. Moreover, BRS
was reported to decrease in patients with IR and in the offspring of
patients with type II DM, including those in whom DM had not
manifested [19]. The mechanism of autonomic dysfunction in these
patients involved an abnormal BP circadian rhythm, reduced BP, and
a sympathetic vagal tone that decreased from day to night.
Autonomic dysfunction preexists in patients with IR and may be
a trigger for the development of hypertension or DM. Moreover, it
was reported that autonomic function was impaired, characterized
by sympathetic overactivity, in obese female adolescents (mean age,
12.7 years) who had IR but not impaired b-cell function [20]. In
such cases of metabolic syndrome, autonomic dysfunction occurs in
a younger population with a few other risk factors. Lifestyle
modiﬁcations, including weight reduction and exercise training are
needed to improve such sympathetic overactivity.
Slentz et al. [21] studied the effects of different intensities of an
8-month exercise training program on pancreatic b-cell function in
middle to older aged sedentary, overweight, or mildly obese and
moderately dyslipidemic subjects. They reported that both moder-
ate and vigorous intensity exercise training improved b-cell
function, whereas vigorous exercise intensity led to a compensatory
decrease in insulin secretion, which was not shown in moderate
intensity exercise. They regard vigorous training intensity as
6580% of peak V˙O2, and moderate intensity as 4055% of peak
V˙O2. Vigorous intensity exercise is relatively risky for cardiac
patients. However, it was reported that 7 consecutive days of
supervised aerobic exercise training (1 h/day, 6070% HR reserve)
improved b-cell function and IR in older sedentary individuals [22].
Both the intensity and volume of exercise were lower than that in the
report by Slentz et al. [21]. The intensity required to improve b-cell
function may be at least 6070% HR reserve during daily aerobic
exercise.
Solomon et al. [23] showed that improved pancreatic b-cell
function in patients with type II DM was obtained after lifestyle
modiﬁcation including 6065% maximum HR intensity exercise
following 8085% exercise for 1 h/day and 5 days/week, and diet
therapy for reducing 300 kcal/day total caloric intake. They also
showed a mean weight decrease of 5.0 kg and improved insulin
secretion from b-cells that was directly related to glucose-
dependent insulinotropic polypeptide. Comprehensive interven-
tions, including exercise and diet therapy, will be needed for
prediabetic patients who do not have drug therapy indications. No
correlation between the change in b-cell function and the changes
in exercise tolerance and HR dynamics was obtained in the present
study. The b-cell functions did not improve after 3 months’training in all groups, because the duration and intensity of
exercise training seemed to be relatively short and mild compared
with the studies previously reported.
Study limitations
First, this study was designed retrospectively and was
performed in a relatively small patient population. We carefully
checked their medical histories from clinical charts, and fasting
glucose and insulin measurements during MI hospitalization,
because the inclusion of patients with DM among the present
study subjects may confound the results. Additionally, the HR
recovery in Group C tended to be lower, but not signiﬁcantly. This
might be caused by the small study population number. Further, it
was suspected that their autonomic dysfunction was relatively
mild. Patients with such prediabetic b-cell dysfunction may have
relatively mild autonomic dysfunction compared with DM
patients. Finally, a study with a larger study population and with
different levels of severity is warranted.
We used the deﬁnition of IR as a HOMA-IR > 2.0, and impaired
b cell function as a HOMA-b < 50% in the present study, which
were different from those frequently reported in the literature.
Generally, a HOMA-IR > 2.5 and a HOMA-b < 40% have been used
in reports by Western authors. However, it was reported that a
HOMA-IR > 1.73 is useful as a standard for IR and concentration of
coronary risk factors in the Japanese population [24]. Moreover, a
HOMA-b < 50% was deﬁned from the data of Japanese populations
[14]. So, the deﬁnitions of IR and impaired b cell function we used
in the present study could ﬁt appropriately to population in Japan.
Optimal medical therapy after MI has changed dramatically in
this decade and several guidelines for cardiac patients recommend
b-blocker administration after MI. In this study, the incidence of b-
blocker administration was relatively low, approximately 38%. This
may be because we included patients across a relatively long study
period to evaluate the relationship between autonomic dysfunc-
tion and b-cell function. However, optimal medical treatment
including coronary reperfusion therapy and rehabilitation were
also performed equally.
Conclusions
Exercise training effects on functional capacity were attenuated
even in patients with MI complicated by pancreatic b-cell
dysfunction. It may be caused by attenuated HR reserve increase
against exercise training. Comprehensive treatment including
vigorous exercise training as well as drugs to improve b-cell
function should be considered for such prediabetic patients.
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